CONGO Specialties Drive Over 50% of NCR Private Hospital Revenue

A report by BNP Paribas Research reveals that five medical specialties—cardiology, oncology, neurology, gastroenterology, and orthopaedics—contributed over 50% of FY25 revenue for private hospitals in the National Capital Region. These CONGO specialties saw revenue growth at 8-33% CAGR between FY22 and FY25, outpacing overall hospital revenue growth. The NCR remains the crucial home market for most listed hospital chains, with 43% of their upcoming bed capacity planned for North India, primarily in the NCR. Market dynamics vary, with South Delhi being the most developed micro-market, while Gurgaon faces potential disruption and Noida holds long-term potential.

Key Points: NCR Hospitals: 5 Specialties Generate Over 50% Revenue

  • CONGO specialties fuel growth
  • NCR is home market for hospitals
  • South Delhi most developed micro-market
  • 43% new beds planned for North India
3 min read

Five specialties account for over 50 pc FY25 revenue in NCR's private hospitals: Report

Cardiology, oncology, neurology, gastroenterology, and orthopaedics drive over half of FY25 revenue for private hospitals in Delhi-NCR, a report finds.

"We believe the success of private hospitals in NCR is determined by revenue contribution from CONGO mix - BNP Paribas Report"

New Delhi, Jan 13

Cardiology, oncology, neurology, gastroenterology, and orthopaedics contributed over 50 per cent of revenue in FY25 in private hospitals in the National Capital region, according to a report.

The report by BNP Paribas Research focuses extensively on private hospitals in the NCR (Gurgaon, Delhi, and Noida) to understand the positioning of private hospital chains across micro-markets, patient mobility to the NCR, and other factors that determine a hospital's success.

It showed that the specialties spiked revenue at 8-33 per cent CAGR between FY22 and FY25.

"We believe the success of private hospitals in NCR is determined by revenue contribution from CONGO mix (cardiology, oncology, neurology, gastroenterology, and orthopaedics), which contributed over 50 per cent of revenue in FY25 for listed hospitals," the report said.

"We believe the contribution from NCR from these specialties would be higher than in other regions. Over FY22-25, revenue from these specialties grew at 8-33 per cent CAGR (vs 15-20 per cent overall revenue CAGR over the same period), which highlights companies' focus on scaling these segments," it added.

The report found that NCR is considered the home market for most listed hospitals in India. It is due to the significant number of beds in the region and high revenue exposure.

Based on the announced expansion, c43 per cent of the upcoming bed capacity for the largest 13 listed hospitals is in North India, mostly NCR.

Government institutional setup, availability of critical treatment, and patients' mobility also determined the market dynamics in Delhi, Gurgaon, and Noida.

"Each market has a different market leader. We expect some disruption in Gurgaon as new players are expected to enter. Noida holds great long-term potential for a substantial patient pool from Uttar Pradesh," the report said.

Yet, Delhi emerged as the most important healthcare market as it's a preferred destination for patients in North India.

It is because Delhi caters to a large volume of patients from nearby states of Uttar Pradesh, Haryana, Rajasthan, and other parts of India.

Within Delhi City, South Delhi emerged as the most developed micro-market, with the presence of several institutions, the report said.

North Delhi, although a larger micro-market compared to South Delhi due to large patient inflow from northern districts of Haryana, has been relatively under-penetrated.

Notably, the boundaries of the NCR healthcare market have been expanding with new hospitals in Faridabad (a district in Haryana and part of the NCR) and Manesar (a town in Gurgaon and part of the NCR), the report said.

- IANS

Share this article:

Reader Comments

P
Priya S
As someone from Lucknow, I can confirm this. My father had a complex heart issue and we were advised to go to Delhi. The entire ecosystem there - specialists, technology - is unmatched in UP. But it's so expensive! The report mentions Noida's potential, I really hope quality healthcare becomes more accessible in our state soon.
R
Rohit P
Not surprising at all. Gurgaon and South Delhi are the MedTech hubs. But this report makes me worry - if 43% of new beds are in North India/NCR, are we neglecting other regions? Healthcare should not be so centralized. What about the South or the East? 🏥
S
Sarah B
Interesting analysis. The "CONGO" mix is a clever acronym. The growth rates (8-33% CAGR) are staggering. This shows where hospital chains are investing. As an investor, this is very useful data. The focus on scaling these high-revenue specialties is clear from the numbers.
V
Vikram M
While the report is about business, we must remember the human cost. Orthopaedics and neurology are huge because of road accidents! Our terrible traffic and driving sense feed this revenue stream. Prevention is better than cure, yaar. The government needs to look at this data from a public health angle too.
K
Kavya N
The part about patient mobility is key. People from smaller towns have zero trust in local hospitals for serious issues. They will sell land to get treatment in Delhi. This report validates that trend. It's a sad reality but true. We need to build trust in healthcare systems across all tiers.

We welcome thoughtful discussions from our readers. Please keep comments respectful and on-topic.

Leave a Comment

Minimum 50 characters 0/50